Jpmorgan Chase & CO Nevro Corp Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVRO
# of Institutions
162Shares Held
38MCall Options Held
44KPut Options Held
1.69M-
Arrow Mark Colorado Holdings LLC Denver, CO4.29MShares$22.9 Million0.48% of portfolio
-
Armistice Capital, LLC New York, NY3.67MShares$19.6 Million0.4% of portfolio
-
Black Rock Inc. New York, NY3.6MShares$19.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.36MShares$12.6 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.93MShares$10.3 Million0.08% of portfolio
About NEVRO CORP
- Ticker NVRO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 35,387,800
- Market Cap $189M
- Description
- Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...